Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of brostallicin in treating patients who
have locally advanced or metastatic soft tissue sarcoma that has not responded to one
previous chemotherapy regimen.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC